Search:
   

System Status Messages

Time Market Status
08:44:52 ETNASDAQSatellos Bioscience Inc. (MSLE) will be released on NASDAQ today for quotation at 09:50 a.m. ET and trading at approximately 10:00 a.m. ET. Please call 877-308-0523 if you have any questions. Reminder: Trading prohibited during quote only period. Per Rule 4120(c)(9), this new issue is eligible for participation in the IPO Cross. 

Regulatory Messages

Time Market Status
18:33:29 ETNASDAQ
BX
PSX
NASDAQ Options
BX Options
NASDAQ Futures
ISE
GEMX
MRX		There are no messages available

IPO Messages

Time Market Status
15:16:23 ETISE
GEMX
MRX
NASDAQ Options
PHLX
BX Options

Nasdaq PHLX, Nasdaq BX Options, Nasdaq ISE, Nasdaq MRX, Nasdaq Options Market & Nasdaq GEMX will remove symbol ANY before the opening on, Monday, February 9, 2026. All open GTC orders in symbol ANY will be cancelled after the close of business today. Please contact Nasdaq Option Listings at 215-496-1266 with any questions.



12:39:54 ETNASDAQ

IPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) has officially opened for trading.

Time: 12:34:03
Price: $14.70
Shares: 692,426

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





12:30:19 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:20:12 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:14:04 ETNASDAQ

IPO Notice Update: The initial public offering of SkyGlass Pharma, Inc.  (SGP) has officially opened for trading.

Time: 12:12:11
Price: $24
Shares: 192,400

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





12:10:46 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:10:08 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:00:57 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:00:26 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:51:10 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:50:35 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:40:55 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:40:04 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:31:03 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:30:04 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:21:36 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:20:28 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:10:13 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:10:02 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:00:44 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:00:14 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:50:26 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:50:03 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:41:10 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:40:18 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:35:23 ETNASDAQ

IPO Notice Update: The initial public offering of Cambridge Acquisition Corp. (CAQUU) has officially opened for trading.

Time: 10:33:59
Price: $9.99
Shares: 1,478,358

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





10:30:40 ETNASDAQIPO Notice Update: The initial public offering of SpyGlass Pharma, Inc. (SGP) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:30:16 ETNASDAQIPO Notice Update: The initial public offering of Agomab Therapeutics (AGMB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:25:15 ETNASDAQ

IPO Notice Update: The initial public offering of SPACSphere Acquisition Corp. (SSACU) has officially opened for trading.

Time: 10:24:38
Price: $10.05
Shares: 616,500

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





10:15:48 ETNASDAQ

IPO Notice Update: The initial public offering of Satellos Bioscience Inc. (MSLE) has officially opened for trading.

Time: 10:14:24
Price: $11.65
Shares:15,250

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





08:36:20 ETNASDAQIPO Notice: The initial public offering of Cambridge Acquisition Corp. (CAQUU) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


08:29:27 ETNASDAQIPO Notice: The initial public offering of SPACSphere Acquisition Corp. (SSACU) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


08:25:20 ETNASDAQIPO Notice: The initial public offering of Agomab Therapeutics (AGMB) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


08:18:04 ETNASDAQIPO Notice: The initial public offering of SpyGlass Pharma, Inc. (SGP) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.



Self-Help Messages

Time Market Status
18:33:29 ETNASDAQ
BX
PSX
NASDAQ Options
NASDAQ Futures
BX Options
PHLX
ISE
GEMX
MRX		There are no messages available